Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry
NCT05196061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-04-13
Summary
Bacterial and fungal microbiota will be different between individual body sites; however, particular microbiome profiles both whole-body and site-specific will be unique to volunteers with a given parameter such as medical diagnosis, diet, medications taken, geographical area; etc.
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
Questionnaire
Subjects will be asked to complete a questionnaire. The questionnaire will garner demographic data, medical history, medication and supplement history, gut-specific, skin-specific questions; etc. The complete questionnaire is provided with this submission for review. Demographic data includes: 1. Age 2. Sex 3. Race 4. Ethnicity
- OTHER
-
Stool sample
Stool samples will be collected using a specific kit consisting of a ready-to-use package, including a user guide. When stool samples are collected, they will be immediately placed in previously prepared Fast prep tubes (MP, Cat# 5076-200-34340) containing 500 μL glass beads (Sigma-Aldrich G8772-100g) and 1 mL ASL™ lysis buffer (Qiagen DNA Extraction Kit) and transported to the laboratory where assays will be conducted. Samples will be kept in a - 20 degree Celsius freezer until they are analyzed.
- OTHER
-
Skin swab
Skin swabbing is a safe, non-invasive method to sample microbiota on human skin. Areas to be swabbed: Right upper back, Non-dominant ventral forearm or Most representative lesion
- OTHER
-
Oral rinse
Briefly, 20-25 ml saline will be provided in separately labelled blue capped 50-mL Falcon™ centrifuge tubes (Fisher Scientifics Co.). Each subject will be asked to swish and gargled the saline from the tube into their mouth for 2 minutes and expectorate the rinse into the tube. The tubes will be closed tightly and stored in -80 C until sequencing can be completed. Prior to use, all the tubes with oral wash samples will be completely thawed on ice, then centrifuged at 4000 rpm for 15 minutes and 20-25 ml supernatant transferred into fresh 50-mL centrifuge tubes. The pellet left in each tube will be used to extract DNA for microbiome studies
Sponsors & Collaborators
-
University Hospitals Cleveland Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Study of Human Microbiota in Healthy and Pathological Conditions
NCT03460392 ·Status: UNKNOWN
-
Implications of the Human Microbiota for Health and Disease
NCT04203303 ·Status: RECRUITING
-
Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
NCT04440631 ·Status: COMPLETED
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NCT06156956 ·Status: RECRUITING ·Phase: NA
-
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases
NCT04689074 ·Status: COMPLETED
-
Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)
NCT06095076 ·Status: UNKNOWN
-
Pathogen-microbiome Interaction During Helicobacter Pylori Infection
NCT05121025 ·Status: RECRUITING
-
Multi-Antibiotic Resistance Carriage in Gut Flora
NCT01591538 ·Status: COMPLETED
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 ·Status: COMPLETED ·Phase: PHASE4
-
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
NCT06258551 ·Status: RECRUITING
-
Uterine Microbiome in Women with Repeated Implantation Failure and Normal Fertile Women
NCT03405883 ·Status: COMPLETED
-
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
NCT07313865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses
NCT05537909 ·Status: RECRUITING ·Phase: NA
-
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221 ·Status: COMPLETED
-
Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network
NCT04937361 ·Status: COMPLETED
-
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02840656 ·Status: COMPLETED
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
NCT04698148 ·Status: COMPLETED
-
Assessing the Performance of Shotgun Metagenomics in the Diagnosis of Complex Prosthetic Joint Infections
NCT06062251 ·Status: RECRUITING
-
Comparison of Gut Microbiota in Sedentary and Active Women
NCT02901912 ·Status: COMPLETED
-
Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.
NCT05169255 ·Status: COMPLETED ·Phase: PHASE3